| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $73.0M | +202.1% |
| Cost of Revenue | $64.7M | +52.4% |
| Gross Profit | $8.3M | +145.1% |
| R&D Expense | $9.4M | +28.4% |
| SG&A Expense | $23.0M | +22.6% |
| Operating Income | -$46.6M | -0.8% |
| Pre-tax Income | -$44.0M | +1.4% |
| Income Tax | $0 | — |
| Net Income | -$44.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $90.5M | +64.0% |
| Accounts Receivable | $23.7M | +325.4% |
| Inventory | $6.7M | +2.4% |
| Current Assets | $126.4M | +83.9% |
| Total Assets | $156.9M | +29.5% |
| Current Liabilities | $17.9M | +3.8% |
| Total Liabilities | $53.1M | +2.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.1M | +6.7% |
| Capital Expenditures | $4.4M | +37.2% |
| Investing Cash Flow | -$4.4M | -37.2% |
| Financing Cash Flow | $71.0M | +50.7% |
| Free Cash Flow | -$35.5M | +2.8% |
| +1.4% |
| EPS (Basic) | -$0.35 | +22.2% |
| EPS (Diluted) | -$0.35 | +22.2% |
| Stockholders' Equity |
| $103.8M |
| +49.4% |